This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Rocket Stocks to Buy in July

Johnson & Johnson

You won't find a more prototypical blue-chip stock than Johnson & Johnson (JNJ - Get Report). This $297 billion health care giant owns a slew of consumer brands with household names, and it pays a hefty 2.67% dividend yield at current price levels. And with rising analyst expectations this week, JNJ is making the Rocket Stock cut this morning.

>>4 Stocks Rising on Unusual Volume

Johnson & Johnson has a reputation that precedes it. The firm's consumer brands include major labels like Band-Aid, Tylenol, Neutrogena and Acuvue but it's the firm's non-consumer pharmaceutical and medical device units that provide the lion's share of Johnson & Johnson's sales. JNJ's diversified product portfolio provides investors with a lot more protection than a typical big pharma or medical device firm would enjoy. Black clouds like patent expiration are mitigated by the fact that JNJ is pulling revenues from multiple sources.

From a financial standpoint, Johnson & Johnson is in solid shape. While the acquisition of big-ticket medical device maker Synthes used a big chunk of JNJ's net available cash, the firm still carries $12.1 billion in net cash on its balance sheet right now. Look for a strong drug pipeline to add some potential growth catalysts to JNJ's huge income statement in the medium-term.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
CBS $55.91 0.00%
JNJ $112.08 0.00%
LEN $45.31 0.00%
PCLN $1,343.66 0.00%
WDC $40.86 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs